Loading grant details…
Propelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare environments
| Funder | European Commission |
|---|---|
| Recipient Organization | Universidad Politecnica de Madrid |
| Country | Spain |
| Start Date | Jan 01, 2025 |
| End Date | Dec 31, 2028 |
| Duration | 1,460 days |
| Number of Grantees | 52 |
| Roles | Participant; Associated Partner; Third Party; Coordinator |
| Data Source | European Commission |
| Grant ID | 101166707 |
Grant Description
The healthcare sector is hindered by several barriers that hamper the application of circular economy principles (e.g. the safety restrictions of the domain limit the use of recycled materials due to the need of materials biocompatibility, and safety in products to be used in the human body).
Led by a multidisciplinary consortium of 39 partners (plus 13 industry affiliates) from 15 EU countries plus UK and USA, ENKORE aim to tackle challenges and develop an ecoDesign framework that supports the development of safe and environmental compliant devices eco-responsible packaging, which minimize the environmental impact, reduce the carbon footprint, and maximize the use and preservation of resources.
The main goal is to connect the design of the medical devices packages with the end-of-life stage, thus the technologies that support circularity are taken into account at the medical device conception stage.
ENKORE framework will be validated in 5 Reference Use Cases (RUCs), led by 5 different health regions that bring HPCs and policy maker, 3 large EU hospitals and the reference network for European Regional and Local Health Authorities (EUREGHA).
The project developments and RUCs are supported by several associations and NGOs, a packaging manufacturer and a group of SMEs and researchers, specialists in circularity, LCA, social sciences, environment, circularity, and materials.
The validation of the framework shall provide evidence to work with policymakers, creating new or revised standards and create tangible/quantitative evidence. Policy making and regulatory engagement will be strongly performed.
The methods and tools comprise Environmental and Social Life Cycle Assessment (ELCA/SLCA), Circularity Calculator (CC) and Digital Product Passport (DPP) approaches, which could be adapted during the second stage of the proposal.
All Grantees
Consorcio Mar Parc de Salut de Barcelona; International Solid Waste Association; Politechnika Poznanska; Enosi Asthenon Elladas; Pfizer Limited; Lilly Deutschland Gmbh; Johnson & Johnson Medical Gmbh; Pfizer Manufacturing Deutschland Gmbh Mit Sitz Illertissen; Universiteit Leiden; Fresenius Medical Care Deutschland Gmbh; Fundacion Universidad Francisco de Vitoria; Technovative Solutions Ltd; Takeda Pharmaceuticals International Ag; Forum Des Patients Europeens; Happy Mondays Communication Sl; Osai Automation System Spa Societa' Benefit; Dupont de Nemours (Luxembourg) Sarl; Universita Campus Bio Medico Di Roma; Pfizer Ireland Pharmaceuticals; Depuy International Limited; Idryma Technologias Kai Erevnas; Boehringer Ingelheim Pharma Gmbh &Co Kg; Servicio Madrileno de Salud; Agenzia Regionale Per la Salute Ed Il Sociale; Active Ageing Association; Sofradim Production Sasu; Tech Hive Labs Astiki Mi Kerdoskopiki Etaireia; Medtronic Iberica Sa; Samenwerkende Topklinische Opleidingsziekenhuizen; Udg Alliance; Boehringer Ingelheim Internationalgmbh; Charite - Universitaetsmedizin Berlin; European Regional and Local Health Authorities Asbl; World Resources Forum Association; Pfizer Italia S.R.L.; Sterimed Holding; Johnson & Johnson Services, Inc.; Naucnoistrazivacki Institut Verlab Za Biomedicinski Inzinjering Medicinske Uredaje I Vjestacku Inteligenciju; Pfizer Inc; Universytet Medyczny W Lodzi.; Predictby Research and Consulting S.L.; Novo Nordisk A/S; Multimed Engineers Srl; Eli Lilly and Company Ltd; Eli Lilly Danmark A/S; Baxter R and D Europe; Eli Lilly and Company; Fondazione Policlinico Universitario Campus Bio Medico; Universidad Politecnica de Madrid; Pfizer R&D Uk Limited; Boehringer Ingelheim Pharmaceuticals, Inc.; Institoyto Bioiatrikis Texnologias
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Related Grants
